DIN 02406411 — HALOPERIDOL INJECTION, USP 5 MG
HALOPERIDOL INJECTION, USP is a solution of Haloperidol Decanoate marketed by FRESENIUS KABI CANADA LTD. The full Haloperidol Decanoate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02406411
- Brand name
- HALOPERIDOL INJECTION, USP
- Active ingredient
- Haloperidol Decanoate
- Strength
- 5 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Butyrophenone antipsychotic (first-generation/typical antipsychotic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Haloperidol Decanoate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02366010 | HALOPERIDOL INJECTION | 5 MG | SOLUTION | JUNO PHARMA CANADA INC. | MARKETED |